• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部光疗。

Ocular phototherapy.

机构信息

Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Eye (Lond). 2013 Feb;27(2):190-8. doi: 10.1038/eye.2012.258. Epub 2012 Dec 14.

DOI:10.1038/eye.2012.258
PMID:23238445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3574257/
Abstract

Phototherapy can be translated to mean 'light or radiant energy-induced treatment.' Lasers have become the exclusive source of light or radiant energy for all applications of phototherapy. Depending on the wavelength, intensity, and duration of exposure, tissues can either absorb the energy (photocoagulation, thermotherapy, and photodynamic therapy (PDT)) or undergo ionization (photodisruption). For phototherapy to be effective, the energy has to be absorbed by tissues or more specifically by naturally occurring pigment (xanthophyll, haemoglobin, and melanin) within them. In tissues or tumours that lack natural pigment, dyes (verteporphin, Visudyne) with narrow absorption spectrum can be injected intravenously that act as focal absorbent of laser energy after they have preferentially localized within the tumour. Ocular phototherapy has broad applications in treatment of ocular tumours. Laser photocoagulation, thermotherapy, and PDT can be delivered with low rates of complications and with ease in the outpatient setting. Review of the current literature suggests excellent results when these treatments are applied for benign tumours, particularly for vascular tumours such as circumscribed choroidal haemangioma. For primary malignant tumours, such as choroidal melanoma, thermotherapy, and PDT do not offer local tumour control rates that are equivalent or higher than those achieved with plaque or proton radiation therapy. However, for secondary malignant tumours (choroidal metastases), thermotherapy and PDT can be applied as a palliative treatment. Greater experience is necessary to fully comprehend risks, comparative benefits, and complication of ocular phototherapy of ocular tumours.

摘要

光疗可以被翻译为“光或辐射能诱导的治疗”。激光已经成为光疗所有应用的光或辐射能的唯一来源。根据波长、强度和暴露时间的不同,组织可以吸收能量(光凝、热疗和光动力疗法(PDT))或发生电离(光破坏)。为了使光疗有效,能量必须被组织吸收,或者更具体地说,被组织中天然存在的色素(叶黄素、血红蛋白和黑色素)吸收。在缺乏天然色素的组织或肿瘤中,可以静脉注射具有窄吸收光谱的染料(verteporfin、Visudyne),这些染料在肿瘤内优先定位后,成为激光能量的局灶性吸收剂。眼部光疗在眼部肿瘤的治疗中有广泛的应用。激光光凝、热疗和 PDT 可以在门诊环境中以低并发症发生率和轻松的方式进行。对当前文献的回顾表明,这些治疗方法对良性肿瘤,特别是局限性脉络膜血管瘤等血管肿瘤,效果极佳。对于原发性恶性肿瘤,如脉络膜黑色素瘤,热疗和 PDT 并不能提供与斑块或质子放射治疗相当或更高的局部肿瘤控制率。然而,对于继发性恶性肿瘤(脉络膜转移瘤),热疗和 PDT 可以作为姑息治疗。需要更多的经验来全面了解眼部肿瘤的眼部光疗的风险、相对益处和并发症。

相似文献

1
Ocular phototherapy.眼部光疗。
Eye (Lond). 2013 Feb;27(2):190-8. doi: 10.1038/eye.2012.258. Epub 2012 Dec 14.
2
Lasers for the treatment of intraocular tumors.激光治疗眼内肿瘤。
Lasers Med Sci. 2013 May;28(3):1025-34. doi: 10.1007/s10103-012-1052-0.
3
Transpupillar laser phototherapy for retinal and choroidal tumors: a rational approach.经瞳孔激光光凝疗法治疗视网膜和脉络膜肿瘤:一种合理的方法。
Graefes Arch Clin Exp Ophthalmol. 2000 Mar;238(3):249-72. doi: 10.1007/s004170050352.
4
Photodynamic therapy of eye diseases.眼部疾病的光动力疗法。
J Ophthalmic Nurs Technol. 2000 May-Jun;19(3):134-41.
5
[Light-based inflammatory acne treatments].[基于光的炎性痤疮治疗方法]
Hautarzt. 2018 Jan;69(1):27-34. doi: 10.1007/s00105-017-4099-9.
6
Thermotherapy in the management of choroidal melanoma.
Prog Retin Eye Res. 2002 May;21(3):303-17. doi: 10.1016/s1350-9462(02)00005-8.
7
Transpupillary laser phototherapy of tumors and vascular anomalies of retina and choroid: theoretical approach and clinical implications.视网膜和脉络膜肿瘤及血管异常的经瞳孔激光光疗:理论方法与临床意义
Technol Health Care. 2000;8(2):93-112.
8
Low Power Single Laser Activated Synergistic Cancer Phototherapy Using Photosensitizer Functionalized Dual Plasmonic Photothermal Nanoagents.基于光敏剂功能化双等离子体光热纳米制剂的低功率单激光激活协同癌症光疗。
ACS Nano. 2019 Feb 26;13(2):2544-2557. doi: 10.1021/acsnano.8b09552. Epub 2019 Feb 11.
9
Photodynamic therapy for circumscribed choroidal haemangioma: a case report.局限性脉络膜血管瘤的光动力疗法:一例报告
J Indian Med Assoc. 2011 Oct;109(10):759-61.
10
Experimental and clinical standards, and evolution of lasers in neurosurgery.神经外科中激光的实验与临床标准及发展历程
Acta Neurochir (Wien). 1996;138(10):1135-47. doi: 10.1007/BF01809742.

引用本文的文献

1
Violet Light Effects on the Circadian Rest-Activity Rhythm and the Visual System.紫光对昼夜休息-活动节律及视觉系统的影响。
Clocks Sleep. 2024 Aug 14;6(3):433-445. doi: 10.3390/clockssleep6030029.
2
Blue Light Exposure: Ocular Hazards and Prevention-A Narrative Review.蓝光暴露:眼部危害与预防——一篇叙述性综述
Ophthalmol Ther. 2023 Apr;12(2):755-788. doi: 10.1007/s40123-023-00675-3. Epub 2023 Feb 18.
3
Advances in the treatment of intraocular malignancies: A literature review.眼内恶性肿瘤治疗进展:文献综述
Front Med (Lausanne). 2022 Oct 18;9:975565. doi: 10.3389/fmed.2022.975565. eCollection 2022.
4
Current Therapeutics and Future Perspectives to Ocular Melanocytic Neoplasms in Dogs and Cats.犬猫眼部黑素细胞肿瘤的当前治疗方法及未来展望
Bioengineering (Basel). 2021 Dec 20;8(12):225. doi: 10.3390/bioengineering8120225.
5
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema.阈下红色(670纳米)与黄色(577纳米)微脉冲激光治疗糖尿病性黄斑水肿的1年视力和解剖学结果比较
Pharmaceuticals (Basel). 2021 Oct 28;14(11):1100. doi: 10.3390/ph14111100.
6
Non-Therapeutic Laser Retinal Injury.非治疗性激光视网膜损伤
Int J Ophthalmic Res. 2019;5(1):321-335. doi: 10.17554/j.issn.2409-5680.2019.05.90. Epub 2019 Nov 26.
7
Mitochondria as Potential Targets and Initiators of the Blue Light Hazard to the Retina.线粒体作为蓝光对视网膜危害的潜在靶点和启动子。
Oxid Med Cell Longev. 2019 Aug 21;2019:6435364. doi: 10.1155/2019/6435364. eCollection 2019.

本文引用的文献

1
Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.结节性硬化症:视网膜表现的基因型/表型相关性。
Ophthalmology. 2012 Sep;119(9):1917-23. doi: 10.1016/j.ophtha.2012.03.020. Epub 2012 May 16.
2
Clinical and histopathologic findings after photodynamic therapy of choroidal melanoma.脉络膜黑色素瘤光动力疗法后的临床和组织病理学发现。
Retina. 2012 May;32(5):942-8. doi: 10.1097/IAE.0b013e31825097c1.
3
Photodynamic therapy for choroidal metastasis in 8 cases.8 例脉络膜转移瘤的光动力疗法。
Ophthalmology. 2012 Jun;119(6):1218-22. doi: 10.1016/j.ophtha.2011.12.024. Epub 2012 Mar 3.
4
Photodynamic therapy: current evidence and applications in dermatology.光动力疗法:皮肤病学中的当前证据及应用
Semin Cutan Med Surg. 2011 Dec;30(4):199-209. doi: 10.1016/j.sder.2011.08.001.
5
Photodynamic therapy of choroidal hemangioma in sturge-weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas.斯特奇-韦伯综合征脉络膜血管瘤的光动力疗法,兼论弥漫性和局限性脉络膜血管瘤的治疗方法。
Surv Ophthalmol. 2011 Jan-Feb;56(1):68-85. doi: 10.1016/j.survophthal.2010.08.002. Epub 2010 Nov 13.
6
Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma.六只眼视网膜毛细血管瘤的维替泊芬光动力疗法。
Acta Ophthalmol. 2010 Dec;88(8):e334-40. doi: 10.1111/j.1755-3768.2010.02008.x. Epub 2010 Oct 14.
7
Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control in 650 consecutive cases.瘤周脉络膜黑色素瘤的瘤床放疗:650 例连续病例的肿瘤控制。
Ophthalmology. 2011 Feb;118(2):402-7. doi: 10.1016/j.ophtha.2010.06.007. Epub 2010 Sep 1.
8
Photodynamic therapy of eyelid basal cell carcinoma.眼睑基底细胞癌的光动力疗法
J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1083-7. doi: 10.1111/j.1468-3083.2009.03195.x. Epub 2009 Mar 11.
9
Photodynamic therapy using methyl aminolevulinate acid in eyelid basal cell carcinoma: a 5-year follow-up study.使用甲基氨基乙酰丙酸进行光动力疗法治疗眼睑基底细胞癌:一项5年随访研究。
Ophthalmic Plast Reconstr Surg. 2009 Mar-Apr;25(2):115-8. doi: 10.1097/IOP.0b013e31819a4404.
10
Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas.使用维替泊芬进行光动力疗法以诱导侵袭性视网膜星形细胞瘤消退。
Acta Ophthalmol. 2008 Nov;86(7):794-9. doi: 10.1111/j.1755-3768.2007.01151.x. Epub 2008 Aug 27.